CNBX Pharmaceuticals (CNBX Pharmaceuticals) Price-to-Tangible-Book : (As of May. 31, 2024)

View and export this data going back to 2007. Start your Free Trial

What is CNBX Pharmaceuticals Price-to-Tangible-Book?

As of today (2024-05-31), CNBX Pharmaceuticals's share price is $0.009. CNBX Pharmaceuticals's Tangible Book per Share of Feb. 2024 for the quarter that ended in Feb. 2024 was $-0.08. Hence, CNBX Pharmaceuticals's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for CNBX Pharmaceuticals's Price-to-Tangible-Book or its related term are showing as below:

During the past 13 years, CNBX Pharmaceuticals's highest Price to Tangible Book Ratio was 2800.11. The lowest was 2.83. And the median was 23.11.

CNBX's Price-to-Tangible-Book is not ranked ^*
in the Biotechnology industry.
Industry Median: 2.77
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, CNBX Pharmaceuticals's share price is $0.009. CNBX Pharmaceuticals's Book Value per Sharefor the quarter that ended in Feb. 2024 was $-0.08. Hence, CNBX Pharmaceuticals's P/B Ratio of today is .

CNBX Pharmaceuticals Price-to-Tangible-Book Historical Data

The historical data trend for CNBX Pharmaceuticals's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CNBX Pharmaceuticals Price-to-Tangible-Book Chart

CNBX Pharmaceuticals Annual Data

Trend

Aug14

Aug15

Aug16

Aug17

Aug18

Aug19

Aug20

Aug21

Aug22

Aug23

Price-to-Tangible-Book

Get a 7-Day Free Trial

3.22

14.62

13.99

CNBX Pharmaceuticals Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
Price-to-Tangible-Book	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of CNBX Pharmaceuticals's Price-to-Tangible-Book

For the Biotechnology subindustry, CNBX Pharmaceuticals's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CNBX Pharmaceuticals's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CNBX Pharmaceuticals's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where CNBX Pharmaceuticals's Price-to-Tangible-Book falls into.

CNBX Pharmaceuticals Price-to-Tangible-Book Calculation

CNBX Pharmaceuticals's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Feb. 2024 )
	=	0.009	/	-0.076
	=

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

CNBX Pharmaceuticals Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of CNBX Pharmaceuticals's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

CNBX Pharmaceuticals (CNBX Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CNBX Pharmaceuticals Inc (OTCPK:CNBX) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 3 Bethesda Metro Center, Suite 700, Bethesda, MD, USA, 20814

Website

https://www.cnbxpharma.com

CNBX Pharmaceuticals Inc is a biotechnology company. It develops pharmaceuticals focusing on cancer research utilizing HTS technology and personalized bioinformatics tools. The company's main focus is the development of cannabinoid therapies and other technologies for the treatment of cancer, mainly cancers of the gastrointestinal tract, skin, breast, and prostate. The firm's main product is the RCC-33, an oral capsule for the treatment of colorectal cancer. The company tools include delivery systems, personalized medicine diagnostics, and therapies based on Cannabinoid compounds.

Executives

Cannabics Inc.	10 percent owner	108 WEST 13TH ST., WILMINGTON DE 19801
Thomas E Mills	director, officer: President, CEO, CFO
North American Mining Corp	10 percent owner	6767 WEST TROPICANA AVENUE, SUITE 229, LAS VEGAS NV 89103
Lou Hilford	director, officer: Vice-President, Secretary